EPI-001, a compound active against castration-resistant prostate cancer, targets transactivation unit 5 of the androgen receptor

Castration-resistant prostate cancer is the lethal condition suffered by prostate cancer patients that become refractory to androgen deprivation therapy. EPI-001 is a recently identified compound active against this condition that modulates the activity of the androgen receptor, a nuclear receptor t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ACS Chem Biol
Main Authors: De Mol, Eva, Fenwick, R. Bryn, Phang, Christopher T. W., Buzón, Victor, Szulc, Elzbieta, de la Fuente, Alex, Escobedo, Albert, García, Jesús, Bertoncini, Carlos W., Estébanez-Perpiñá, Eva, McEwan, Iain J., Riera, Antoni, Salvatella, Xavier
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5027137/
https://ncbi.nlm.nih.gov/pubmed/27356095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acschembio.6b00182
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados